REQUEST A DEMO
Total
USD $0.00
Search more companies

Inspirapharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Inspirapharma Sdn. Bhd. Profile Updated: January 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Inspirapharma Sdn. Bhd. is a company in Malaysia, with a head office in Sungai Petani. It operates in the Pharmaceutical and Medicine Manufacturing industry. Inspirapharma Sdn. Bhd. was incorporated on June 08, 2004. The latest financial highlights indicate a net sales revenue drop of 0.65% in 2024. Its total assets decreased by 26.84% over the same period. The net profit margin of Inspirapharma Sdn. Bhd. increased by 16.12% in 2024.

Headquarters
Lot 24 & 25, Jalan 8, Kawasan Perusahaan, Bakar Arang
Sungai Petani; Kedah; Postal Code: 08000

Contact Details: Purchase the Inspirapharma Sdn. Bhd. report to view the information.

Website: http://www.pharmaniaga.com

Basic Information
Registered Capital:
Purchase the Inspirapharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Inspirapharma Sdn. Bhd. report to view the information.
Incorporation Date:
June 08, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Inspirapharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.65%
Total Operating Revenue
-0.65%
Operating Profit
235.62%
Net Profit/Loss for the Period
432.5%
Total Assets
-26.84%
Total Equity
2.42%
Operating Profit Margin
17.01%
Net Profit Margin
16.12%
Return on Equity (ROE)
21.23%
Quick Ratio
25.14%
Cash Ratio
2.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?